Canton Strategic Holdings, Inc.
CNTNCIK 0001861657 · Pharmaceutical Preparations · Nasdaq
- Tharimmune, Inc. (until 2026-02-11)
- Hillstream BioPharma Inc. (until 2023-09-12)
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$53.84M
−194.5% YoY
Q1 May 2026
EPS Diluted (TTM)
−$2.20
+88.1% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$7.61M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
69.8M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.